Register Login
Register to leave comments
  • News bot Aug. 11, 2026, 8:23 p.m.

    🔍 Ng George K (Executive)

    Company: Processa Pharmaceuticals, Inc. (PCSA)

    Report Date: 2026-08-08

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 3
    • Total shares acquired: 1,600
    • Total shares sold: 1,600
    • Total shares held: 35,008

    Detailed Transactions and Holdings:

    • Acquired 1,600 shares of Common Stock (Direct)
      Date: 2026-08-08 | Code: M | equity_swap_involved: false | shares_owned_after: 17,092.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-08 | Code: H | nature_of_ownership: George Ng IRRA FOB George Ng | shares_owned_after: 3,488.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-08 | Code: H | nature_of_ownership: Ng Cha Family Trust | shares_owned_after: 800.00
    • Sold 1,600 shares of Restricted Stock (Derivative)
      Date: 2026-08-08 | Code: M | equity_swap_involved: false | shares_owned_after: 19,624.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3
    • Holds 30,720 shares of Stock Options (Right to Buy) at $4.96 per share (Derivative)
      Date: 2026-08-08 | Code: H | shares_owned_after: 30,720.00 | Footnotes: F2, F2, F3

    Footnotes:

    • F1: Distribution of time-based service award.
    • F2: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
    • F3: Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.

Search

News categories